#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile psoriatic arthritis Haemophilia A with anti factor VIII Progressive multifocal leukoencephalopathy Vitamin B12 deficiency Wolfram syndrome Monogenic diabetes Cardiac failure acute Myocarditis Pulmonary arterial hypertension Acute on chronic liver failure Congenital growth hormone deficiency Anti-glomerular basement membrane disease Richter's syndrome Astrocytoma malignant Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Trials in Disease Combined immunodeficiency – Treatment Lymphangiosarcoma – Basic Information Cerebral arteriovenous malformation haemorrhagic – Diagnostics Castleman’s disease Waldenstrom’s macroglobulinaemia – Basic Information Progressive supranuclear palsy – Trials in Disease Primary biliary cholangitis – Basic Information Pemphigoid – Trials in Disease Usher’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Concizumab Gimeracil Dexlansoprazole Tenecteplase Antithymocyte Immunoglobulin Human Immunoglobulin G Fampridine Neridronate Sodium Cetrorelix Demeclocycline Hydrochloride Mirikizumab Faricimab Raxtozinameran Alxn2220 Rapcabtagene Autoleucel Prednisolone Sodium Succinate Cholic Acid ARGININE GLUTAMATE GUAIACOL Satoreotide Tetraxetan More therapies…

    Learn about Your Condition

    Tardive dyskinesia Neuroblastoma recurrent Addison's disease Breast angiosarcoma metastatic Advanced systemic mastocytosis Malignant melanoma Tinnitus Factor IX deficiency Systemic scleroderma Adenosquamous cell lung cancer Bile acid synthesis disorder Oedema Dysmenorrhoea Lichenoid keratosis Retinoblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Aticaprant Oral Tablet vs Small IV Dose to Measure How Well It Is Absorbed in Healthy Adults

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Aticaprant
    Belgium

  • Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hot flush
    • Menopausal symptoms
    • Testosterone deficiency syndrome
    Investigated Drugs:
    • Elinzanetant
    Germany

  • Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Nemtabrutinib
    • Zilovertamab Vedotin
    Czechia Estonia Germany Ireland Italy Poland +3

  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Belgium Czechia Germany Hungary Italy The Netherlands +1

  • A study to evaluate how the body processes AZ-3102 in healthy male subjects

    Not recruiting

    1 1 1
    Investigated Drugs:
    • (2S,3R,4R,5S)-1-[5-(2-FLUORO-BIPHENYL-4-YLMETHOXY)-PENTYL]-2-HYDROXYMETHYL-PIPERIDINE-3,4,5-TRIOL
    The Netherlands

  • Bioequivalence Study of Ulipristal Acetate 30 mg Tablet in Healthy Subjects Under Fasting Conditions

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Ulipristal Acetate
    Portugal
Previous Page
1 … 926 927 928 929 930 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!